The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ertapenem Injection Market Research Report 2025
Synopsis
Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.
The global Ertapenem Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ertapenem Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ertapenem Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ertapenem Injection include Merck, Endo, Aurobindo Pharma and ACS Dobfar, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ertapenem Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Injection.
Report Scope
The Ertapenem Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ertapenem Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ertapenem Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Endo
Aurobindo Pharma
ACS Dobfar
Segment by Type
1g/Vial
Others
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ertapenem Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ertapenem Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.
The global Ertapenem Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ertapenem Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ertapenem Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ertapenem Injection include Merck, Endo, Aurobindo Pharma and ACS Dobfar, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ertapenem Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Injection.
Report Scope
The Ertapenem Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ertapenem Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ertapenem Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Endo
Aurobindo Pharma
ACS Dobfar
Segment by Type
1g/Vial
Others
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ertapenem Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ertapenem Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ertapenem Injection Market Overview
1.1 Product Overview and Scope of Ertapenem Injection
1.2 Ertapenem Injection Segment by Type
1.2.1 Global Ertapenem Injection Market Value Comparison by Type (2024-2030)
1.2.2 1g/Vial
1.2.3 Others
1.3 Ertapenem Injection Segment by Application
1.3.1 Global Ertapenem Injection Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Ertapenem Injection Market Size Estimates and Forecasts
1.4.1 Global Ertapenem Injection Revenue 2019-2030
1.4.2 Global Ertapenem Injection Sales 2019-2030
1.4.3 Global Ertapenem Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ertapenem Injection Market Competition by Manufacturers
2.1 Global Ertapenem Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ertapenem Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ertapenem Injection Average Price by Manufacturers (2019-2024)
2.4 Global Ertapenem Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ertapenem Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ertapenem Injection, Product Type & Application
2.7 Ertapenem Injection Market Competitive Situation and Trends
2.7.1 Ertapenem Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ertapenem Injection Players Market Share by Revenue
2.7.3 Global Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ertapenem Injection Retrospective Market Scenario by Region
3.1 Global Ertapenem Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ertapenem Injection Global Ertapenem Injection Sales by Region: 2019-2030
3.2.1 Global Ertapenem Injection Sales by Region: 2019-2024
3.2.2 Global Ertapenem Injection Sales by Region: 2025-2030
3.3 Global Ertapenem Injection Global Ertapenem Injection Revenue by Region: 2019-2030
3.3.1 Global Ertapenem Injection Revenue by Region: 2019-2024
3.3.2 Global Ertapenem Injection Revenue by Region: 2025-2030
3.4 North America Ertapenem Injection Market Facts & Figures by Country
3.4.1 North America Ertapenem Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ertapenem Injection Sales by Country (2019-2030)
3.4.3 North America Ertapenem Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ertapenem Injection Market Facts & Figures by Country
3.5.1 Europe Ertapenem Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ertapenem Injection Sales by Country (2019-2030)
3.5.3 Europe Ertapenem Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ertapenem Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Ertapenem Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ertapenem Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Ertapenem Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ertapenem Injection Market Facts & Figures by Country
3.7.1 Latin America Ertapenem Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ertapenem Injection Sales by Country (2019-2030)
3.7.3 Latin America Ertapenem Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ertapenem Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ertapenem Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ertapenem Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ertapenem Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ertapenem Injection Sales by Type (2019-2030)
4.1.1 Global Ertapenem Injection Sales by Type (2019-2024)
4.1.2 Global Ertapenem Injection Sales by Type (2025-2030)
4.1.3 Global Ertapenem Injection Sales Market Share by Type (2019-2030)
4.2 Global Ertapenem Injection Revenue by Type (2019-2030)
4.2.1 Global Ertapenem Injection Revenue by Type (2019-2024)
4.2.2 Global Ertapenem Injection Revenue by Type (2025-2030)
4.2.3 Global Ertapenem Injection Revenue Market Share by Type (2019-2030)
4.3 Global Ertapenem Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ertapenem Injection Sales by Application (2019-2030)
5.1.1 Global Ertapenem Injection Sales by Application (2019-2024)
5.1.2 Global Ertapenem Injection Sales by Application (2025-2030)
5.1.3 Global Ertapenem Injection Sales Market Share by Application (2019-2030)
5.2 Global Ertapenem Injection Revenue by Application (2019-2030)
5.2.1 Global Ertapenem Injection Revenue by Application (2019-2024)
5.2.2 Global Ertapenem Injection Revenue by Application (2025-2030)
5.2.3 Global Ertapenem Injection Revenue Market Share by Application (2019-2030)
5.3 Global Ertapenem Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Ertapenem Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Ertapenem Injection Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Endo
6.2.1 Endo Corporation Information
6.2.2 Endo Description and Business Overview
6.2.3 Endo Ertapenem Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Endo Ertapenem Injection Product Portfolio
6.2.5 Endo Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Ertapenem Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Ertapenem Injection Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 ACS Dobfar
6.4.1 ACS Dobfar Corporation Information
6.4.2 ACS Dobfar Description and Business Overview
6.4.3 ACS Dobfar Ertapenem Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ACS Dobfar Ertapenem Injection Product Portfolio
6.4.5 ACS Dobfar Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ertapenem Injection Industry Chain Analysis
7.2 Ertapenem Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ertapenem Injection Production Mode & Process
7.4 Ertapenem Injection Sales and Marketing
7.4.1 Ertapenem Injection Sales Channels
7.4.2 Ertapenem Injection Distributors
7.5 Ertapenem Injection Customers
8 Ertapenem Injection Market Dynamics
8.1 Ertapenem Injection Industry Trends
8.2 Ertapenem Injection Market Drivers
8.3 Ertapenem Injection Market Challenges
8.4 Ertapenem Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
